Publication | Open Access

Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention

NanomedicineEngineeringAnti-restenotic Agent Db103Polymer-drug ConjugateTargeted DeliveryMedicineTherapeutic NanomaterialsCyclodextrin-based NanospongesNano-drug DeliveryWound HealingBiomedical EngineeringDrug Delivery SystemPharmacology